1. Provision of an inhaled glucocorticoid and instruction on its use led to a significantly lower rate of severe asthma ...
Click to read the study in Clinical Cancer Research.
1. This multi-centered, randomized controlled trial demonstrated that 12 mg and 6 mg dexamethasone daily had similar efficacy for days ...
1. Ruxolitinib was shown to significantly improve failure-free survival for glucocorticoid-refractory chronic graft-versus-host disease (GVHD) compared to control therapy. 2. ...
1. This phase III drug trial showed that dexamethasone does not significantly reduce risk of adverse events and death following ...
1. Reduced-dose glucocorticoid plus rituximab regimen was non-inferior compared to high-dose glucocorticoid plus rituximab regimen for induction of disease remission ...
1. In this retrospective cohort study, the risk of an atypical fracture increased with longer duration of bisphosphonate use while ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.
Subscribe for free today!